These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The effect of nitric oxide synthase inhibition on acute platelet accumulation and hemodynamic depression in a rat model of thromboembolic stroke. Stagliano NE; Zhao W; Prado R; Dewanjee MK; Ginsberg MD; Dietrich WD J Cereb Blood Flow Metab; 1997 Nov; 17(11):1182-90. PubMed ID: 9390650 [TBL] [Abstract][Full Text] [Related]
26. Minimum hematocrit for normothermic cardiopulmonary bypass in dogs. Cook DJ; Orszulak TA; Daly RC; MacVeigh I Circulation; 1997 Nov; 96(9 Suppl):II-200-4. PubMed ID: 9386098 [TBL] [Abstract][Full Text] [Related]
27. Effects of nitric oxide donor and nitric oxide synthase inhibitor on the resistance, exchange and capacitance functions of the canine intestinal vasculature. Hsieh NK; Chang HR; Hu CT; Chen HI Vascul Pharmacol; 2008; 48(2-3):122-8. PubMed ID: 18295548 [TBL] [Abstract][Full Text] [Related]
28. Hemodynamic effects of nitric oxide synthase inhibition before and after cardiac arrest in infant piglets. Schleien CL; Kuluz JW; Gelman B Am J Physiol; 1998 Apr; 274(4):H1378-85. PubMed ID: 9575943 [TBL] [Abstract][Full Text] [Related]
29. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats. Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G Br J Pharmacol; 1993 Sep; 110(1):428-34. PubMed ID: 8220904 [TBL] [Abstract][Full Text] [Related]
30. Effects of chronic nitric oxide synthase inhibition on cerebral arterioles in rats. Chillon JM; Ghoneim S; Baumbach GL Hypertension; 1997 Nov; 30(5):1097-104. PubMed ID: 9369262 [TBL] [Abstract][Full Text] [Related]
32. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs. Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566 [TBL] [Abstract][Full Text] [Related]
33. Role of nitric oxide in hypoxic cerebral vasodilatation in the ovine fetus. Hunter CJ; Blood AB; White CR; Pearce WJ; Power GG J Physiol; 2003 Jun; 549(Pt 2):625-33. PubMed ID: 12665609 [TBL] [Abstract][Full Text] [Related]
34. Effect of L-arginine on metabolic recovery of the ischemic myocardium. Carrier M; Khalil A; Tourigny A; Solymoss BC; Pelletier LC Ann Thorac Surg; 1996 Jun; 61(6):1651-7. PubMed ID: 8651764 [TBL] [Abstract][Full Text] [Related]
35. Perfusate viscosity and hematocrit determine pulmonary vascular responsiveness to NO synthase inhibitors. Wilson PS; Khimenko P; Moore TM; Taylor AE Am J Physiol; 1996 May; 270(5 Pt 2):H1757-65. PubMed ID: 8928883 [TBL] [Abstract][Full Text] [Related]
36. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies. Buhimschi IA; Shi SQ; Saade GR; Garfield RE Am J Obstet Gynecol; 2001 Mar; 184(4):686-93. PubMed ID: 11262473 [TBL] [Abstract][Full Text] [Related]
37. Synchronous oscillations in cerebrocortical capillary red blood cell velocity after nitric oxide synthase inhibition. Biswal BB; Hudetz AG Microvasc Res; 1996 Jul; 52(1):1-12. PubMed ID: 8812747 [TBL] [Abstract][Full Text] [Related]
38. Cerebral blood flow is reduced by N omega-nitro-L-arginine methyl ester during delayed hypoperfusion in cats. Clavier N; Kirsch JR; Hurn PD; Traystman RJ Am J Physiol; 1994 Jul; 267(1 Pt 2):H174-81. PubMed ID: 8048583 [TBL] [Abstract][Full Text] [Related]
39. Cerebrovascular consequences of repeated exposure to NG-nitro-L-arginine methyl ester. Kelly PA; Ritchie IM; Collins FM Br J Pharmacol; 1995 Nov; 116(6):2771-7. PubMed ID: 8591003 [TBL] [Abstract][Full Text] [Related]